Cancer Stem Cell News Volume 2.39 | Oct 2 2013

    Cancer Stem Cell News 2.39 October 2, 2013

    Cancer Stem Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Cancer Stem Cell News on Twitter

    Paracrine Activation of WNT/β-Catenin Pathway in Uterine Leiomyoma Stem Cells Promotes Tumor Growth
    Investigators uncovered a paracrine role of the wingless-type (WNT)/β-catenin pathway that enables mature myometrial or leiomyoma cells to send mitogenic signals to neighboring tissue stem cells in response to estrogen and progesterone, leading to the growth of uterine leiomyomas. [Proc Natl Acad Sci USA] Abstract
    Use Aldefluor to Detect Breast Cancer Stem Cells - Click here to learn more

    PUBLICATIONS (Ranked by impact factor of the journal)
    A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem-Like Cells into S/G2/M-Phases
    Investigators explored the use of a genetically engineered telomerase-specific oncolytic adenovirus, OBP-301 to mobilize the cell cycle and kill quiescent cancer stem-like cells. [Clin Cancer Res] Abstract

    CD44 Expressed on CAFs Is a Functional Molecule Supporting the Stemness and Drug Resistance of Malignant Cancer Cells in the Tumor Microenvironment
    Scientists showed that cancer-associated fibroblasts (CAFs) support tumor growth in vivo and maintain the stemness of cancer stem/initiating cells in an in vitro model using an established CAF cell line. [Stem Cells] Abstract

    Inhibition of Monocarboxylate Transporter-4 Depletes Stem-Like Glioblastoma Cells and Inhibits HIF Transcriptional Response in a Lactate-Independent Manner
    Researchers found that monocarboxylate transporter-4 (MCT4) knockdown was associated with a decreased percentage of glioblastoma cells expressing the stem-cell marker CD133 and increased apoptotic fraction. They also found that flow-sorted CD133-positive cells had almost sixfold higher MCT4 levels than CD133-negative cells, suggesting that the stem-like population might have a greater requirement for MCT4. [Oncogene] Abstract

    Tumor Resident Mesenchymal Stromal Cells Endow Naïve Stromal Cells with Tumor-Promoting Properties
    Using a mouse lymphoma model, scientists showed that lymphoma resident mesenchymal stem/stromal cells are able to confer tumor-promoting property to naïve cocultured bone marrow mesenchymal stem/stromal cells. [Oncogene] Abstract

    In Vivo 5FU-Exposed Human Medullary Thyroid Carcinoma Cells Contain a Chemoresistant CD133+ Tumor-Initiating Cell Subset
    Researchers investigated whether Glycoprotein Prominin-1 (CD133)+ cells derived from human medullary thyroid carcinoma possess tumor-initiating properties in vivo and exhibit differential responses to chemotherapeutic agents. [Thyroid] Abstract

    Physiological Beta-Catenin Signaling Controls Self-Renewal Networks and Generation of Stem-Like Cells from Nasopharyngeal Carcinoma
    HONE1 hybrid cells displayed stem cell-like properties, including enhancement of CD24+ and CD44+ populations and generation of spheres that were not observed in parental HONE1 cells. [BMC Cell Biol] Abstract | Full Article

    miR-34 Is Associated with Poor Prognosis of Patients with Gallbladder Cancer through Regulating Telomere Length in Tumor Stem Cells
    The miR34a level and telomere length were measured in 77 gallbladder adenocarcinomas and 36 peritumoral tissues by real-time PCR. Forced miR34a expression was established by an adenovirus carrying a miR34a expression cassette. The colony-forming ability of isolated CD44+CD133+ gallbladder cancer tumor stem-like cells was measured by matrigel colony assay. [Tumour Biol] Abstract

    Isolation and Characterization of Squamous Cell Carcinoma-Derived Stem-Like Cells: Role in Tumor Formation
    Since epithelial tumors originate from keratinocyte stem cells, investigators evaluated the features of rapidly adhering keratinocytes derived from primary human squamous cell carcinoma of the skin. [Int J Mol Sci] Abstract | Full Article

    The Deubiquitinase USP28 Stabilizes LSD1 and Confers Stem-Cell-Like Traits to Breast Cancer Cells
    Using an unbiased siRNA screening against all the human deubiquitinases, investigators identified USP28 as a bona fide deubiquitinase of LSD1. USP28 interacted with and stabilized LSD1 via deubiquitination. USP28 overexpression correlated with LSD1 upregulation in multiple cancer cell lines and breast tumor samples. [Cell Rep] Full Article | Graphical Abstract

    NeuroCult™ for Brain Tumor Research - View Publications

    Molecular Insight in Gastric Cancer Induction: An Overview of Cancer Stemness Genes
    This review analyzes and investigates the main genetic factors involved in tumorogenesis of gastric cancer and the molecular mechanism of their expression regulation alongside with the importance of cancer stem cells and their relationship with gastric cancer. [Cell Biochem Biophys] Abstract

    Visit our reviews page to see a complete list of reviews in the cancer stem cell research field.

    Stem Cell Society Singapore 2013 Symposium

    National Cancer Institute Awards $48.6 Million Grant to MD Anderson
    Broad, deep and outstanding research in cancer science, treatment and prevention have earned The University of Texas MD Anderson Cancer Center a $48.6-million, five-year grant from the National Cancer Institute and an “exceptional” ranking, the highest possible, from the National Cancer Institute’s extensive peer-review process. [The University of Texas MD Anderson Cancer Center] Press Release

    Verastem Initiates Phase II Trial of Defactinib in Lung Cancer
    Verastem, Inc. announced the initiation of a Phase II trial of defactinib (VS-6063), a potent inhibitor of focal adhesion kinase, in KRAS-mutated non-small cell lung cancer. [Verastem, Inc.] Press Release

    New wallchart from our sponsor:
    Mesenchymal Stem Cells (a Nature Reviews Molecular Cell Biology collaboration). Request your free copy.

    US Government Shuts Down
    The US government entered a state of suspended animation on 1 October after Congress failed to agree on a budget for the next fiscal year, causing federal agencies – including those overseeing science policy and research – to shut down indefinitely. Most government scientists were ordered to stay at home, their offices and labs closed or run by a skeleton staff of ‘essential’ workers. The National Institutes of Health and the National Science Foundation stopped processing grants, some government websites were made inaccessible and many important research programmes were left hanging, potentially putting lives at risk in the case of some disease studies. [Nature News] Editorial

    NEW Cell Culture World Congress 2014
    February 25-27, 2014
    Munich, Germany

    NEW 9th Annual World Stem Cells & Regenerative Medicine Congress 2014
    May 20-22, 2014
    London, United Kingdom

    Visit our events page to see a complete list of events in the cancer stem cell community.

    NEW Postdoctoral Position – RNA & Stem Cell Biology (Cancer Research Centre of Lyon)

    Postdoctoral Position – Breast Cancer Stem Cell Biology (UC College of Medicine)

    Research Associate – Leukemia & Stem Cell Biology (King’s College London)

    Tenure Track Faculty Positions – Cancer Biology (Memorial Sloan-Kettering Cancer Center)

    Assistant Professor – Developmental and Stem Cell Biology (METU Department of Biology)

    Principal Scientist – Cancer Stem Cells (Pharma Professionals Europe Ltd)

    Scientist – Particle Chemistry (STEMCELL Technologies Inc.)

    Research Technologist – Human Pluripotent Stem Cell Products (STEMCELL Technologies Inc.)

    Research Technologist – Mesenchymal Cell Research (STEMCELL Technologies Inc.)

    Research Technologist – Cell Culture Media & Matrices (STEMCELL Technologies Inc.)

    Research Associate/Scientist – Antibodies Group (STEMCELL Technologies Inc.)

    Research Associate – Particle Chemistry (STEMCELL Technologies Inc.)

    Quality Control Analyst – Media (STEMCELL Technologies Inc.)

    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.


    Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!

    Comments or Suggestions? Email with your feedback.

    Learn more about Cancer Stem Cell News: Archives | Events | Contact Us